1Wong IH, Lo YM. New markers for cancer detection[J]. Curt Oncol Rep, 2002, 4(6) :471.
2Fehm T, Sagalowsky A, Clifford E, et al. Cytogenetic evidence that circulating epithelial cells in patients with eaxeinoma axe malignant[J]. Clin Cancer Re.s, 2002, 8(7):2073.
3Sozzi G, Musso K, Ratcliffe C, et al. Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients:a prospect for early diagnosis[J]. Clin Cancer Res, 1999, 5(10):2689.
4Silva JM, Silva J, Sanchez A, et al. Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival[J]. Clin Cancer Res, 2002, 8(12):3761.
5Sanchez-Cespedes M, Alarendt SA, Piantadosi S, et al. Chromosomal Alterations in lung adenocarcinoma from smokers and nonsumokers[J ]. Cancer Res,2001,61 (4) : 1309.
6Sasatomi E, Finkelstein SD, Woods JD, et al. Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage Ⅱ non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value[J].Cancer Res,2002,62(9) :2681.
7Yatabe Y, Konishi H, Mitsudomi T, et al. Topographical distrlbutions of allelic loss in individual non-small-cell lung cancers[J]. Am J Pathol., 2000,157(3) : 985.
8Yamasaki M, Takeshima Y, Fujii S, et al. Correlation between morphological heterogeneity and genetic alteration within one tumor in adenocarcinomas of the lung[J ]. Pathol Int, 2000, 50(1):891.
9Boyle J O, Lonardo F, Chang J H, et al. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutitions[J]. Clin Cancer Res, 2001,7(2) :259.
10Sozzi G, Conte D, Mariani L, et al. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients[J]. Caneer Res, 2001, 61(12):4675.
